Penserra Capital Management’s cbdMD YCBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,528
Closed -$12K 1451
2023
Q4
$12K Hold
1,528
﹤0.01% 1081
2023
Q3
$12K Hold
1,528
﹤0.01% 1070
2023
Q2
$17K Buy
1,528
+11
+0.7% +$288 ﹤0.01% 1183
2023
Q1
$106K Buy
1,517
+24
+2% +$2.23K ﹤0.01% 765
2022
Q4
$122K Buy
1,493
+24
+2% +$2.42K ﹤0.01% 779
2022
Q3
$119K Hold
1,469
﹤0.01% 720
2022
Q2
$232K Buy
1,469
+71
+5% +$16.8K 0.01% 656
2022
Q1
$523K Sell
1,398
-754
-35% -$255K 0.01% 492
2021
Q4
$836K Buy
2,152
+141
+7% +$82K 0.02% 435
2021
Q3
$1.5M Buy
2,011
+142
+8% +$119K 0.03% 376
2021
Q2
$1.95M Buy
1,869
+180
+11% +$215K 0.04% 343
2021
Q1
$2.52M Buy
1,689
+1,071
+173% +$1.56M 0.05% 295
2020
Q4
$654K Buy
618
+347
+128% +$315K 0.02% 348
2020
Q3
$194K Sell
271
-184
-40% -$176K 0.01% 439
2020
Q2
$312K Buy
455
+70
+18% +$31.4K 0.02% 429
2020
Q1
$128K Buy
385
+300
+353% +$118K 0.01% 512
2019
Q4
$35K Buy
85
+21
+33% +$25.2K ﹤0.01% 733
2019
Q3
$90K Buy
+64
New +$103K 0.01% 558

Other funds holding YCBD

Penserra Capital Management's YCBD Position: Q1 2024 in Review

Penserra Capital Management sold out of cbdMD (YCBD) in Q1 2024, closing a stake of 1,528 shares — an estimated $12K sold.

Penserra Capital Management first reported a position in YCBD in Q3 2019 and held it in 18 quarters. The position peaked at $2.52M in Q1 2021. 19 funds tracked by Wall St. Rank hold YCBD as of Q1 2024.

  • Penserra Capital Management reported no remaining cbdMD position as of Q1 2024 after selling out during the quarter.
  • Penserra Capital Management sold 1,528 cbdMD shares in Q1 2024, an estimated $12K.
  • Penserra Capital Management first reported a position in cbdMD in Q3 2019 and held it in 18 quarters.
  • Penserra Capital Management's cbdMD position peaked at $2.52M in Q1 2021.
  • 19 funds tracked by Wall St. Rank held cbdMD as of Q1 2024.

Based on Penserra Capital Management's 13F filing for Q1 2024, filed 15 May 2024.